Nandish Shah recommends a Bull spread on Glenmark Pharma for January series

Pharma as a sector looking good on the short term chart, according to Nandish Shah of HDFC Securities.

Markets, stocks, buy, sell, trading, shares, stock market
Nandish Shah Mumbai
1 min read Last Updated : Dec 31 2021 | 8:45 AM IST
Bull spread strategy on Glenmark Pharma

Buy Glenmark Jan 530 CALL at Rs 21 and simultaneously sell 550 CALL at Rs 13

Lot size 1,150

Cost of the strategy Rs 8 (Rs 9,200 per strategy)

Maximum profit Rs 13,800 if Glenmark closes at or above 550 on 27 Jan expiry.

Breakeven Point Rs 538

Rationale:
  • We have seen long build up in the Glenmark Futures, where we have seen 16%(Prov) rise in the Open Interest with price rising by 2%.
  • Stock price has broken out on the daily chart to close at highest level since 13-Dec.
  • Short term trend remain bullish as stock price is trading above its 5 and 20 day EMA.
  • RSI and MFI Oscillators are placed above 60 and sloping upwards, indicating strength in the current uptrend.
  • Pharma as a sector looking good on the short term chart.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Stock callsGlenmark PharmaceuticalsHDFC SecuritiesMarketsderivatives tradingDerivative calls

Next Story